SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
RavenQuest BioMed Inc. (RVVQF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RVVQF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.33
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2009 |
$0.00 |
$0.00 |
$-90.71K |
- |
| 2010 |
$0.00 |
$0.00 |
$-82.07K |
- |
| 2011 |
$0.00 |
$0.00 |
$-110K |
- |
| 2012 |
$0.00 |
$0.00 |
$100.5K |
- |
| 2013 |
$-0.02 |
$0.00 |
$-502K |
- |
| 2014 |
$0.00 |
$0.00 |
$-60.57K |
- |
| 2015 |
$0.00 |
$0.00 |
$-76.03K |
- |
| 2016 |
$0.00 |
$0.00 |
$-81.46K |
- |
| 2017 |
$-0.10 |
$112.35K |
$-3.3M |
-2938.1% |
| 2018 |
$-0.33 |
$1.26M |
$-30.47M |
-2423.9% |
